signaling gateway home
registrationelectronic alerthelpcontact ussite guidesearch
cell signaling update signaling update home updates  news  research library featured articles conferences

Inflammation: The double-deal for NFkappaB inhibitors

Exclusive to Signaling Gateway

NF-kappaB has a dual function as an initiator of systemic inflammation and as an apoptosis inhibitor in sites of injury caused by intestinal ischemia-reperfusion.

The transcription factor NF-kappaB is activated upon infection and inflammation, but confirmation as to whether NF-kappaB mediates inflammatory responses—or is merely a marker thereof—has been elusive. Now, Michael Karin and his colleagues have selectively deleted the catalytic subunit of IKK essential for NF-kappaB activation, IkappaB (IKK)-beta, in intestinal epithelial cells to reveal a role of NF-kappaB in both the inflammatory response as well as in the suppression of apoptosis.

Previous attempts to create chemical inhibitors of NF-kappaB have resulted in lethality due to apoptosis of the developing liver, driven by tumor necrosis factor (TNF)-alpha. Now, the authors have created mice with a conditional loss-of-function allele of IKK-beta (Ikbkb in mice). This mouse model was used to investigate the role of IKK-beta and NF-kappaB in severe systemic inflammation and multiple organ dysfunction syndrome (MODS) caused by gut ischemia-reperfusion. MODS, the leading cause of death in the critically ill, can result in acute respiratory failure and acute respiratory distress syndrome, partly as a result of migratory neutrophils released from the site of reperfusion.

IKK-beta activation was not observed in the lungs of knockout mice subjected to gut ischemia-reperfusion. In contrast, the control mice showed NF-kappaB DNA binding activity. The authors found that activation of IKK, NF-kappaB and lung inflammation in response to gut ischemia-reperfusion depends on the release of the potent IKK activator TNF-alpha. Although the ablation of IKK-beta from intestinal epithelial cells did not interfere with the normal development of the intestinal mucosa, it did significantly reduce neutrophil migration into the lung after gut ischemia-reperfusion, thus preventing lung edema. However, the knockout mice also demonstrated a marked increase in the number of apoptotic cells after gut ischemia-reperfusion, suggesting a role for NF-kappaB as a protector of challenged cells and tissues from apoptosis.

These results show the dual function of the NF-kappaB system in the initiation of systemic inflammation and in tissue protection, but also highlight that NF-kappaB and IKK inhibitors, which could be used to treat inflammatory disorders such as MODS, must be employed with caution.

Julia Howlett, Assistant Editor
Signaling Gateway

References

  1. Chen, Lee-Wei Egan, Laurence Li, Zhi-Wei Greten, Florian R. Kagnoff, Martin F. Karin, Michael The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nature Medicine, 9, 575–581 (2003) 10.1038/nm849 PubMed |

more more stories

 Nature Publishing Group

HOME | SIGNALING UPDATE | MOLECULE PAGES | DATA CENTER | ABOUT US
registration | e-alert | help | contact us | site guide | search

© 2002-2008 Nature Publishing Group

Privacy Policy